Genentech

Lamar experienced cycles of remission and recurrence when he was first diagnosed with Hodgkin’s lymphoma at the age of 25. He underwent treatment with different types of therapies until he eventually went into long term remission. It wasn’t until several years later that he was diagnosed with a completely different type of known as diffuse large B-cell lymphoma (DLBCL). Learn more about Lamar’s inspiring story of resilience, and how clinical trials offered him renewed hope. http://spr.ly/6189mRlQN

ALK is a biomarker that impacts some people with non-small cell lung cancer (NSCLC). As part of a complete diagnosis, every person with lung cancer should be tested early for biomarkers when there is greater opportunity to treat cancer before it spreads. Learning if your cancer is ALK-positive - or if you have any other biomarkers - provides crucial information to inform your treatment plan. Learn more about the biomarker testing process: http://spr.ly/61895qoJJ

Testing a patient’s lung cancer for biomarkers allows doctors to give a complete diagnosis and helps patients start a personalized treatment specific to their type of cancer. ALK is one of these biomarkers seen in non-small cell lung cancer (NSCLC). Patients with ALK-positive NSCLC are typically diagnosed at a younger age than other types of NSCLC. Learn more about biomarker testing: http://spr.ly/61835qoGW

Giving back is an important way that we deliver on Our Promise to serve society. Earlier this month, we held our 15th annual Genentech Gives Back where thousands of our employees came together for a full week of volunteering and giving in South San Francisco and our other Site communities. See below for some of our favorite moments from this meaningful week, and learn more about how we give back locally here: http://spr.ly/618657IPA

When it comes to stroke, time is everything. It can happen to anyone, regardless of age, ethnicity or occupation. In the U.S., about 800K people experience stroke each year, and one in five of those people are under the age of 55. That’s why it’s important for everyone to be aware of their risk factors and learn to recognize the signs. One way to do this is by memorizing, BE FAST which highlights the signs and symptoms to ensure immediate medical care. Read stories from survivors who have experienced a stroke here: http://spr.ly/6184d1guo

Brett’s son, Ben, was diagnosed with multiple food allergies at 11 months old. His allergic reactions have caused several hospital visits and continues to impact his relationship to food. Today, Brett is a vocal advocate as the Leader of the Northern Virginia Food Allergy Group, an initiative dedicated to helping families feel more confident about handling food allergies. This , learn more about food allergies and how they impact 17 million children and adults in the US: https://www.gene.com/stories/living-with-food-allergies.

Not all lung cancers are the same. Some tumors have specific genetic “drivers” called biomarkers that cause cancer to grow and spread. Biomarker testing identifies these drivers and may unlock information about specific types of cancer, including in the lungs. Learn more about biomarker testing here: http://spr.ly/6180jxLqq

Pictured below are Cathy, Jasmine, Christine, and Sue. Each are navigating life with various chronic conditions and face unique challenges every day. Although their journeys may not look the same, they share a common thread - advocating for their well-being, and seeking support to pursue their passions. Whether it’s running a business, being a mother, or empowering others who may be on a similar path as them. This , honor the strength and vulnerability of these women, as well as others who inspire you.

Last week our Gene Academy students, teachers, and mentors got a surprise visit from South San Francisco Assemblymember Diane Papan and South San Francisco Unified School District Superintendent Dr. Shawnterra Moore. During their visit, Assemblywoman Papan and Superintendent Moore observed South City students in the 3rd through 5th grades build compasses and electromagnets in a fun science experiment. At our company, we believe that human connection through mentoring builds confidence in young students and ensures that the future of the healthcare and scientific workforce reflects the diverse communities in which we live. Our Gene Academy is just one of the ways we're doing this. Learn more about the program here: http://spr.ly/6183jH8UW

When Brandon and Amber’s son was diagnosed with A at birth, they were afraid about how it would affect his life. However, support groups and resources gave them comfort and allowed them to meet others in the same position.

“Hemophilia resources helped us realize that our son can live a happy, fulfilling life like any other kid. We hope that future generations continue to create a community for themselves and continue to support each other.”

Learn more about hemophilia A this
https://www.gene.com/topics/hemophilia

For Brandon and Amber, learning to manage their son’s A was a challenge. Thanks to medical advances, they feel more comfortable with him just being a kid. Learn more about how the hemophilia A landscape has been changing. http://spr.ly/6188kfcsp

Today on Rare Disease Day, tune in to watch “Most Likely Not To…” a musical comedy livestream written and performed by the spinal muscular atrophy (SMA) community.

This first-of-its-kind event will highlight the astonishing situations people living with disabilities have found themselves in, due to both ableist notions and inaccessibility.

Support for “Most Likely Not To…” is provided by our SMA My Way program. Watch the livestream starting at 3 pm PT/ 6 pm ET here: https://www.smamyway.com/the-musical/

is often linked to social isolation. But despite being diagnosed with , Barbara leads a very active social life, thanks to regular treatment. She’s now living life to the fullest thanks to regular eye treatments and a tenacious attitude. Eye exams are especially important for people over 50. Schedule yours today.

is an opportunity to celebrate a vibrant and diverse community, and to acknowledge the legacy of systemic inequities that continue to impact the wellbeing of Black people across the U.S. For example, Black women continue to be disproportionately affected by breast cancer but remain underrepresented in clinical research. With support from our Health Equity Innovation Fund, Touch, The Black Breast Cancer Alliance is activating a joyful, energized community of Black women with breast cancer to advocate for themselves and each other to increase access and participation in clinical research. Learn how their groundbreaking initiative, When We Tri(al), is helping more Black women enroll in clinical cancer research: http://spr.ly/6187nXahf

can take a toll on your mental health. For Gary, a diagnosis in 2002 left him feeling distraught. But thanks to regular treatment, he is still able to serve in his community, teach courses to students, and volunteer.

“Early detection is most important,” Gary states. He hopes his story will encourage others to get their eyes checked regularly.

When John went in for his eye exam in 2014, he didn’t expect to be diagnosed with . And thanks to treatment that stabilized his eyesight, John can still enjoy cooking and traveling with his wife, Connie. John hopes his experience will inspire others to get their eyes checked regularly. Schedule your next eye exam today.

Yan Wu, Senior Fellow and Vice President of Antibody Engineering, credits early mentors at Genentech for seeing her potential and trusting her to take on new responsibilities that expanded her skillset and eventually enabled her to rise to the leadership level. She has paid forward that investment in her career by mentoring young talent who bring new ideas to help fuel innovation at our company. In honor of Day, we recognize and thank Yan and all of the mentors who support our employees to flourish in their professional journeys!